Allmed Medical Products Co Ltd Class A (002950) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Allmed Medical Products Co Ltd Class A (002950) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥206.33 Million ≈ $30.19 Million USD) by net assets (CN¥3.75 Billion ≈ $548.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Allmed Medical Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Allmed Medical Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Allmed Medical Products Co Ltd Class A for a breakdown of total debt and financial obligations.
Allmed Medical Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allmed Medical Products Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
|
-0.073x |
|
Aerospace Cf
SHG:600855
|
-0.017x |
|
Guangdong Macro Co Ltd
SHE:000533
|
0.065x |
|
Jiangsu Jiuding New Material Co Ltd
SHE:002201
|
0.069x |
|
WEIBO CORP. A
F:2WB
|
N/A |
|
Csg Smart Science&Technology Co Ltd
SHE:300222
|
0.084x |
|
Novocure Ltd
NASDAQ:NVCR
|
0.060x |
|
Bafang Electric Suzhou Co Ltd
SHG:603489
|
0.017x |
Annual Cash Flow Conversion Efficiency for Allmed Medical Products Co Ltd Class A (2014–2024)
The table below shows the annual cash flow conversion efficiency of Allmed Medical Products Co Ltd Class A from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see 002950 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.45 Billion ≈ $504.56 Million |
CN¥711.64 Million ≈ $104.14 Million |
0.206x | +56.48% |
| 2023-12-31 | CN¥3.21 Billion ≈ $469.86 Million |
CN¥423.50 Million ≈ $61.97 Million |
0.132x | -64.08% |
| 2022-12-31 | CN¥3.13 Billion ≈ $458.16 Million |
CN¥1.15 Billion ≈ $168.24 Million |
0.367x | +169.59% |
| 2021-12-31 | CN¥2.75 Billion ≈ $402.71 Million |
CN¥374.85 Million ≈ $54.85 Million |
0.136x | -72.29% |
| 2020-12-31 | CN¥2.92 Billion ≈ $427.74 Million |
CN¥1.44 Billion ≈ $210.24 Million |
0.492x | +270.55% |
| 2019-12-31 | CN¥2.06 Billion ≈ $301.32 Million |
CN¥273.13 Million ≈ $39.97 Million |
0.133x | +5726.87% |
| 2018-12-31 | CN¥1.32 Billion ≈ $193.40 Million |
CN¥3.01 Million ≈ $440.26K |
0.002x | -98.73% |
| 2017-12-31 | CN¥1.10 Billion ≈ $160.75 Million |
CN¥197.25 Million ≈ $28.86 Million |
0.180x | -61.32% |
| 2016-12-31 | CN¥1.02 Billion ≈ $149.03 Million |
CN¥472.74 Million ≈ $69.18 Million |
0.464x | +112.00% |
| 2015-12-31 | CN¥994.18 Million ≈ $145.48 Million |
CN¥217.68 Million ≈ $31.85 Million |
0.219x | -44.63% |
| 2014-12-31 | CN¥742.08 Million ≈ $108.59 Million |
CN¥293.45 Million ≈ $42.94 Million |
0.395x | -- |
About Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co., Ltd manufactures and sells wound care and nursing material products in China. The company's traditional wound care products include non-woven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton-filled exodontia sponges, packing strips, ribbon gauze, cotton-tipped appli… Read more